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Population aging is a global phenomenon and many 
first world countries will face a situation where, within 
the next twenty years, the largest population cohort will 
be those over 65.1 Reportedly, in 2009, 50.8% of indi-
viduals undergoing cardiac surgery with cardiopulmo-
nary bypass (CPB) were over 69 years of age and 11.8% 
were older than 80 years.2 Age is an established indepen-
dent risk factor for morbidity, mortality and adverse 
events following coronary artery bypass grafting 
(CABG) and a review of the Society of Thoracic 
Surgeons (STS) database showed increased mortality of 
nonagenarians undergoing cardiac surgery.3
Conventional CABG using CECC can be associated 
with severe complications, such as stroke, peripheral 
embolization, acute kidney injury and systemic inflam-
matory response syndrome (SIRS).4 In open-heart sur-
gery, the main etiology for SIRS is blood cell contact with 
the artificial bypass surfaces, such as the oxygenator 
membranes and CPB tubing.5,6 SIRS is characterized by 
complement activation and the release of cytokines and 
vasoactive peptides, which can, subsequently, lead to 
complications, including cardiac arrhythmias, coagulop-
athy or thromboembolism.4 The MECC system was 
engineered in 2000; details have been previously pub-
lished by our group.7 The system was designed to pro-
vide adequate tissue perfusion with much shorter tubing 
and a more biocompatible pump-oxygenator circuit than 
conventional CECC. Previous studies indicate that there 
is a significant reduction in CPB-associated side effects, 
including SIRS, hemolysis, hemodilution and coagulop-
athy.8,9 Data also indicate a reduced need for postopera-
tive transfusions, less renal and myocardial damage, 
shorter length of stay and a lower incidence of sternal 
wound infections, with an explicit benefit in high-risk 
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patients, like those suffering diabetes mellitus (DM) and 
individuals with reduced ejection fraction or chronic 
kidney disease (CKD).10–13 However, limited data are 
currently available regarding elderly patients undergoing 
CABG on MECC. Therefore, the purpose of this retro-
spective study was to evaluate the impact of MECC on 
the early outcome of elderly patients undergoing CABG.
Methods
We reviewed our database of 3909 cases for elderly 
patients who had undergone elective, emergent or urgent 
isolated CABG surgery between January 2005 and 
December 2012 in our institution. Eight hundred and 
seventy-five patients (aged ⩾75 years, mean age 78.35 ± 
2.95 years) underwent CECC (n = 345; 39.4%) or MECC 
(n = 530; 60.6%) and were included. Exclusion criteria 
were heparin-induced thrombocytopenia and combined 
procedure (CABG plus valve or aortic surgery). Baseline 
characteristics of the population are shown in Table 1. 
MECC was not implemented in patients with significant 
aortic insufficiency or a body mass index (BMI) >30 kg/m2. 
Data analysis was performed retrospectively from anon-
ymized data, routinely collected for the German Federal 
Office of Quality Assurance in Cardiac Surgery. 
According to the guidelines in our institution, ethics 
committee approval was not needed for retrospective 
analysis of anonymized data.
Perfusion procedure with CECC
We used an extracorporeal circuit consisting of a diffu-
sion membrane oxygenator (Quadrox 2000, Maquet 
Cardiopulmonary®, Rastatt, Germany) and a non- 
pulsatile roller pump, established for a blood flow of 
2.5 L/min/m2 (HL 30, Maquet Cardiopulmonary®), a 
two-stage cannula (39-50 Fr) (Stöckert®, Munich, 
Germany), draining venous blood from the right atrium, 
and a 22 Fr aortic cannula (Maquet Cardiopulmonary®) 
for the distal ascending aorta. Lost blood was collected 
in an open cardiotomy reservoir and transfused back to 
the patient. The total surface area was >12 m2 and the 
system requires a priming volume of 1200 ml, including 
5000 IU heparin. In addition, 350 IU/kg heparin were 
given as a bolus after harvesting the bypass grafts, with a 
goal activated clotting time (ACT) of >450 seconds. 
We used a single shot of crystalloid cardioplegia 
(Bretschneider HKT, Franz-Koehler-Chemie®, Alsbach-
Haenlein, Germany) or Calafiore blood cardioplegia to 
initiate cardiac arrest, depending on the surgeon’s pref-
erence.
Perfusion procedure with MECC
We used a closed-loop MECC circuit without air-blood 
contact. It consisted of a diffusion membrane oxygenator 
(Quadrox D, Maquet Cardiopulmonary®), a centrifugal 
pump (RotaFlow, Maquet Cardiopulmonary®), a table 
line (3/8”, 2 x 90 cm), a venous two-stage cannula (32-40 
Fr), an aortic cannula (21 Fr) and a 1000-ml infusion bag 
with sodium chloride. The total surface area was <3 m2 
and less than 600 ml of priming volume were required 
without the addition of heparin. The tubing was pre-
pared before surgery, pre-connected and comes com-
pletely coated with heparin. Therefore, an intraoperative 
ACT of 250-300 sec was sufficient and only 150 IU/kg of 
heparin were administered before cross-clamping. In all 
cases, warm Calafiore blood cardioplegia was used. A 
cell-saving device (Cell Saver®, Hemonetics GmbH, 
Table 1. Demographic data and preoperative risk factors.
CECC MECC p-value
No. of patients 345 (39.4%) 530 (60.6%)  
Mean age, (range) years 78.2 ± 2.9 (75 – 91) 78.5 ± 3.0 (75 – 89) 0.14
Gender, male 243 (70.4%) 365 (68.9%) 0.65
Body mass index, kg/m² 28.2 ± 4.2 27.8 ± 3.8 0.15
EuroScore, % 10.8 ± 8.3 10.2 ± 7.8 0.28
Ejection fraction, %  57 ± 15  58 ± 14 0.32
Three vessel disease 287 (83.2%) 423 (79.8%) 0.22
Urgency of surgery  
 Elective 168 (48.7%) 245 (46.2%) 0.49
 Urgent/Emergent 177 (51.3%) 285 (52.8%) 0.49
Acute myocardial infarction 53 (15.4%) 86 (16.2%) 0.78
Previous cardiac surgery 25 (7.2%) 42 (7.9%) 0.79
Diabetes mellitus 114 (33.0%) 154 (29.1%) 0.23
Peripheral vascular disease 71 (20.6%) 93 (17.5) 0.29
Arterial hypertension 259 (75.1%) 416 (78.5%) 0.25
Atrial fibrillation 34 (9.9%) 36 (6.8%) 0.13
Chronic obstructive pulmonary disease 41 (11.9%) 44 (8.3%) 0.10
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Munich, Germany) was used to salvage intraoperative 
blood loss.
Surgical Procedure
The same group of experienced senior surgeons, trained 
and capable to use both MECC and CECC, performed 
all cases. The decision for MECC or CECC was based on 
the discretion of the operating surgeon. In all elective 
cases, platelet inhibitors or anticoagulation were stopped 
seven days prior to surgery, if possible. Heparin was 
stopped six hours preoperatively. All patients under-
went generalized anesthesia with propofol, fentanyl and 
pancuronium per standardized institutional protocol. 
In all cases, a median sternotomy was performed. The 
internal mammary artery (IMA) and either the radial 
artery or the saphenous vein were harvested prior to the 
institution of CPB. In both groups, a brief period of 
hypothermia (34°C) was established. Distal anastomo-
ses were sutured in cardiac arrest. Reperfusion was per-
formed per protocol and CPB was weaned. The chest 
was closed with common sternotomy wires. The patients 
remained sedated and intubated and were transferred to 
the ICU for standardized postoperative weaning and 
care. Extracorporeal circulation time (ECCT), cross-
clamp time and reperfusion time and the number of 
transfused red blood cell (RBC) units were recorded.
Postoperative course
Immediately after arrival in the ICU, labs were collected, 
including complete blood count (CBC), basic metabolic 
panel (BMP) and lactate and cardiac enzymes (T1), 
which were repeated 6 hours postoperatively (T2) and 
on the morning of postoperative day (POD) 1 (T3). 
After the achievement of hemodynamic stability and 
normothermia, sedation and ventilator settings were 
weaned and early extubation was attempted. The 
patients were then transferred to the step-down unit for 
mobilization and later to the regular floor for standard 
postoperative care. All patients were enrolled into car-
diac rehab after discharge. The need for inotropic sup-
port, re-exploration due to bleeding, hemodialysis (HD) 
and RBC transfusion, 48-hr postoperative blood loss, 
duration of mechanical ventilation, ICU and hospital 
stay in days, occurrence of atrial fibrillation (AF), delir-
ium, stroke and infection rates (pulmonary and deep 
sternal wound infections) were monitored. Death of any 
cause within 30 days postoperatively was recorded and 
defined as mortality.
Statistical analysis
We used SPSS 18.0 (SPSS, Chicago, IL) and Stata 10 SE 
(Stata Corp, College Station, TX). Continuous data are 
presented as mean ± SD or as median with interquartile 
range when appropriate. Categorical variables are 
reported as frequency distributions (n) and simple per-
centages (%). Multivariate logistic regression analysis 
for risk factors associated with 30-day mortality was 




Table 1 shows the baseline characteristics and preopera-
tive risk factors of both groups. The MECC group (n=530; 
60.6%) was larger than the CECC group (n=345; 39.4%), 
but no statistically significant differences occurred 
regarding risk factors, including age, gender, BMI, 
EuroScore, left ventricular ejection fraction (LVEF), 
urgency status of surgery, acute infarction, previous sur-
gery, DM, AF, hypertension, chronic obstructive pulmo-
nary disease or peripheral vascular disease.
Intraoperative data
There were no statistically significant differences in the 
use of distal anastomoses between the groups. However, 
in the MECC group, we found a statistically significant 
shorter ECCT (78 ± 27 min versus 95 ± 35 min; p<0.001), 
cross-clamp time (46 ± 16 min versus 53 ± 18 min; 
p<0.001) and reperfusion time (26 ± 14 min versus 34 ± 
19 min; p<0.001), as well as lower RBC transfusion needs 
[n = 177 (33.4%) versus 225 (65.2%); p<0.001](Table 2).
Laboratory data
No significant difference was seen in the baseline labs 
(T0) between the groups. Postoperatively, the only sta-
tistically significant variable was lactate (mg/dL), 
which we found significantly lower in the MECC group 
(T1: 13 ± 12 versus 23 ± 21; p<0.001, T2: 15 ± 17 versus 
28 ± 32; p< 0.001, T3: 10 ± 9 versus 13 ± 8; p<0.001). 
No differences were observed in CBC and creatinine 
(Table 3).
Postoperative course and data
Table 4 reports the postoperative differences of both 
groups. Patients in the MECC group required signifi-
cantly less inotropic support [47 (8.9% versus 56 (16.2%); 
p<0.001], fewer blood transfusions (1 [0 – 2] units versus 
2 [0 – 3] units; p<0.001), less postoperative hemodialysis 
[n = 12 (2.3%) versus n = 20 (5.8%); p=0.009] and devel-
oped less delirium [n = 17 (3.2%) versus n = 22 (6.4%); 
p=0.03] compared to patients in the CECC group. In 
addition, in the MECC group, ICU stay was significantly 
shorter (2 [2 – 4] days versus 3 [2 – 5] days; p<0.01) and 
30-day mortality was significantly reduced [n = 14 
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(2.6%) versus n = 27 (7.8%); p<0.001]. No statistically 
significant difference was found between the groups in 
48-hour postoperative drainage output, need for re-
sternotomy due to bleeding, the occurrence of AF, post-
operative infections (pulmonary and deep sternal wound 
infections), stroke and hospital stay (Table 4).
Independent risk factors for 30-day 
mortality
In addition, we found that duration of CPB (Odds ratio 
1.03, CI 1.02 – 1.04, p<0.001), cross-clamp time (Odds 
ratio 0.97, CI 0.94 – 0.99, p=0.016) and postoperative 
HD (Odds ratio 13.72, CI 5.27 – 35.74, p<0.001) were 
independent risk factors for 30-day mortality. No signifi-
cance was found for CECC, urgency of surgery or blood 
transfusion. The results are summarized in Table 5.
Discussion
In a prior study, patients over 75 years of age were found 
to have no difference in mortality, myocardial infarction 
or stroke if they undergo CABG compared to drug-elut-
ing stent (DES) placement, but a significantly higher 
Table 2. Intraoperative course.
CECC (n = 345) MECC (n = 530) p-value
Use of internal thoracic artery (%) 321 (93.0%) 498 (93.9%) 0.58
Number of distal anastomoses 2.9 ± 0.7 3.0 ± 0.8 0.45
Extracorporeal circulation time, minutes 95 ± 35 78 ± 27 <0.001
Cross-clamp time, minutes 53 ± 18 46 ± 16 <0.001
Reperfusion time, minutes 34 ± 19 26 ± 14 <0.001
Transfusion of red blood cells (%) 225 (65.2%) 177 (33.4%) <0.001
Number of packed red blood cells, unit 1 [0 – 2] 0 [0 – 1] <0.001
Table 3. Biochemical/serological data.
CECC (n = 345) MECC (n = 530) p-value
Hemoglobin (mg/dL)  
 T0 12.1 ± 1.9 12.1 ± 1.6 0.74
 T1 9.9 ± 1.0 9.9 ± 1.9 0.79
 T2 10.4 ± 5.2 10.2 ± 5.2 0.82
 T3 10.9 ± 1.8 11.1 ± 1.7 0.10
Platelets (x 103/µL)  
 T0 240 ± 69 250 ± 87 0.07
 T1 152 ± 52 194 ± 84 0.30
 T2 161 ± 56 168 ± 69 0.13
 T3 217 ± 67 226 ± 79 0.08
Leukocytes (x 103/µL)  
 T0 8.7 ± 5.3 8.2 ± 2.6 0.06
 T1 13.8 ± 14.7 11.8 ± 9.9 0.02
 T2 10.9 ± 8.9 10.4 ± 6.6 0.32
 T3 8.8 ± 3.6 8.5 ± 2.9 0.44
Lactate (mg/dL)  
 T0 12 ± 10 11 ± 8 0.12
 T1 23 ± 21 13 ± 12 <0.001
 T2 28 ± 32 15 ± 17 <0.001
 T3 13 ± 8 10 ± 9 <0.001
Creatinine (mg/dL)  
 T0 1.3 ± 0.9 1.2 ± 0.9 0.21
 T1 1.3 ± 1.1 1.3 ± 1.0 0.73
 T2 1.3 ± 0.9 1.1 ± 0.5 <0.001
 T3 1.4 ± 0.8 1.3 ± 0.7 0.10
Blood samples were collected preoperatively (T0), 30 min after arrival at the intensive care unit (T1), 6 hours after surgery (T2) and at discharge 
(T3).
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incidence of repeat intervention with DES placement.14 
Kahn et al. have shown that more frail and elderly 
patients are undergoing cardiac surgery nowadays than 
10 years ago. They have increased mortality and are at 
increased risk for prolonged ICU stay and adverse 
events, such as stroke, infections and acute kidney injury 
(AKI).15 In their study, about 60% were isolated CABG 
cases, reviewed 2001–2010, and the mortality for 
patients defined as frail was 14%. Patients included in 
their study had an average EuroScore of 6%. A review of 
the STS database for 108 nonagenarians undergoing 
cardiac surgery from 2002 to 2012 showed a high preva-
lence of preoperative cerebrovascular disease (23.1%) 
and arrhythmia (55.6%). Overall, nonagenarian mortal-
ity was 13%.3 Therefore, it is imperative to find lower-
risk solutions for elderly patients undergoing CABG.
Our study reviewed 875 elderly patients, aged 75–91 
years, with a EuroScore of 10.5%, who underwent iso-
lated CABG surgery with either MECC or CECC and 
found significantly reduced ECCT, cross-clamp and rep-
erfusion time, intra- and postoperative RBC transfu-
sions, need for inotropic support and hemodialysis and 
stroke and delirium, as well as shorter ICU stay and 
reduced 30-day mortality in the MECC group. These 
data are mainly consistent with previously published 
results of analyses of other high-risk patient populations 
undergoing CABG. Our group is very experienced with 
MECC and has demonstrated favorable outcome com-
pared to CECC in several previous publications: MECC 
had reduced postoperative mortality, length of stay, 
lower transfusion requirements, less renal and myocar-
dial damage and a lower incidence of sternal wound 
infections in diabetic patients.10 However, in those 
patients, the predicted perioperative risk according to 
the EuroScore was lower (4.9%) than in the elderly popu-
lation evaluated in this study (10.5%). Another previous 
analysis showed that especially high-risk patients of any 
age with a EuroScore >10% had less myocardial damage, 
lower transfusion rates, less AKI and lower 30-day mor-
tality.9 However, this study did not reveal a significant 
difference in postoperative creatinine levels. Independent 
risk factors for 30-day mortality in elderly patients were 
duration of CPB, cross-clamp time and postoperative 
HD, which were all shorter in the MECC group. A previ-
ous analysis of younger patients identified duration of 
CPB, cross-clamp time, AKI and preoperative myocar-
dial infarction as independent risk factors.16
These results allow us to suggest that MECC is not 
only a safe, but also a superior alternative for CABG in 
elderly patients compared to CECC.
Table 4. Postoperative data.
CECC (n = 345) MECC (n = 530) p-value
Inotropic support 56 (16.2%) 47 (8.9%) <0.001
48-hour drainage loss, mL 560 [350 – 850] 550 [350 – 840] 0.65
Re-exploration for bleeding 10 (2.9%) 19 (3.6%) 0.70
Number of packed red blood cells, unit 2 [0 – 3] 1 [0 – 2] <0.001
Duration of ventilation, hours 12 [9 – 17] 11 [8 – 15] <0.01
Postoperative temporary dialysis 20 (5.8%) 12 (2.3%) 0.009
Postoperative atrial fibrillation 28 (8.1%) 58 (5.5%) 0.13
Pulmonary infection 20 (5.8%) 17 (3.2%) 0.08
Deep sternal wound infection 23 (6.7%) 33 (6.2%) 0.78
Delirium 22 (6.4%) 17 (3.2%) 0.03
Stroke 8 (2.3%) 7 (1.3%) 0.29
Intensive care unit stay, days 3 [2 – 5] 2 [2 – 4] <0.01
Hospital stay, days 10 [8 – 12] 9 [8 – 12] 0.45
30-day mortality 27 (7.8%) 14 (2.6%) <0.001
Table 5. Multivariate logistic regression analysis* for risk factors associated with 30-day mortality.
* = Hosmer-Lemeshow-Test x²: p=0.309.
Odds ratio 95% Confidence interval p-value
Conventional extracorporeal circulation 1.75 0.78 – 3.95 0.18
Urgency of surgery 1.14 0.71 – 1.84 0.59
Extracorporeal circulation time 1.03 1.02 – 1.04 0.001
Cross-clamp time 0.97 0.94 – 0.99 0.016
Transfusion of red blood cell 1.45 0.63 – 3.36 0.39
Postoperative temporary dialysis 13.72 5.27 – 35.74 0.001
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Possible explanations for better results with MECC 
have been discussed in detail by prior authors.9,10,17 
Most likely, the reduction of blood-artificial surface 
contact and the reduction in priming volume decrease 
inflammatory response, hemodilution and third spac-
ing. The lower lactate reflects better tissue perfusion 
and less anaerobic cell metabolism, as shown by our 
results in elderly as well as other populations.10 Other 
approaches to reduce mortality in elderly patients 
undergoing CABG are off-pump coronary artery 
bypass grafting (OPCAB) and minimally invasive car-
diac surgery CABG (MICS-CABG). Both have been 
widely discussed in the literature and are controversial 
due to limited exposure of the surgical field, less surgi-
cal control and acuity and hemodynamic instability 
during exposure of the posterior wall. However, the 
GOPCABE study group found that, in patients 75 years 
of age or older, there was no significant difference 
between on-pump and off-pump CABG with regard to 
death, stroke, myocardial infarction, repeat revasculari-
zation or new renal-replacement therapy within 30 
days and 12 months after surgery.18 Even further, van 
Boven et al. reported that, in elderly patients, MECC 
was associated with an improved early postoperative 
respiratory performance and lower transfusion rates 
compared to CECC or OPCAB.19
Our study has some limitations. This was a retro-
spective database analysis from one single center. The 
groups were not randomized or blinded and selection 
bias might contribute. Confounding factors might have 
contributed and influenced the outcome.
Concluding from our results, MECC is superior to 
CECC in 75-91-year-old patients undergoing CABG 
surgery. Especially, reduced ECCT, 30-day mortality 
and lengths of ICU stay, as well as lower transfusion 
rates, encourage the use of MECC in elderly patients.
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